Newsylist real-time news trend intelligence
▲ Peaking Entertainment

Actor Blasts ‘Piece of S**t’ Co-Star Who Quit Movie Mid-Production

5 news sources are covering this Entertainment story right now — Newsylist is tracking how fast it spreads.

5sources
5articles
3velocity
+0%since first seen
1h agofirst detected

Answered

Why is "Actor Blasts ‘Piece of S**t’ Co-Star Who Quit Movie Mid-Production" trending?

Because 5 independent news sources published 5 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

How does Newsylist measure this trend?

Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

Is this trend still active?

The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

Where it stands

"Actor Blasts ‘Piece of S**t’ Co-Star Who Quit Movie Mid-Production" is generating significant coverage in the Entertainment category, with 5 articles from 5 distinct sources tracked by Newsylist so far.

Outlets currently covering the story include AOL.com, Pajiba, News.com.au and People.com. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.

This brief was generated by Newsylist's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

Generated by Newsylist's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.

The reporting (5)

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

3210Aug 1 16:29Aug 1 17:29 UTC

People, places & organizations

Topics

From around our network

Related trends

◼ Archived Health 🔮 holds ✗

First person gets new experimental vaccine for Ebola

The world's first vaccine targeting the Bundibugyo ebolavirus has entered human clinical trials following the first volunteer vaccination.

10 sources 11 articles v 9 6d ago